IL6 and neoplasm: AP1S1 showed enrichment for IL6-JAK-STAT3 and TNFα-NFκB signaling, as well as apoptosis and G2/M checkpoint pathways, suggesting involvement in both metabolic regulation and tumor-immune interactions (Figure 3B, E).